Don’t Miss Out on the Pot Boom and Buy Canopy Growth (TSX:WEED) Now

Get ready for the marijuana boom’s next leg up and buy Canopy Growth Corp (TSX:WEED)(NYSE:CGC).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canada’s booming marijuana industry has been attracting considerable attention, especially since it became the first developed nation to legalize the recreational use of the drug. That event triggered a massive boom among marijuana companies with Canopy Growth (TSX:WEED)(NYSE:CGC) emerging as the industry leader.

The marijuana cultivator has grown from being the first publicly traded marijuana company in North America in early 2014 to now have a market cap of almost $20 billion and poised to enter the S&P/TSX 60 Index. This is a remarkable achievement and highlights why now is the time for investors to add Canopy to their portfolios.

Further market opportunities

Canopy is focused on ramping up its business and expanding at a rapid clip to be the world’s leading cultivator and distributor of marijuana products. The legalization of recreational marijuana use in Canada has also increased pressure south of the border for its recreational consumption to be fully legalized.

Currently, medical consumption of the drug has been legalized in 33 states and 10 of those states, notably California, legally allow recreational use, although marijuana is still illegal under federal law. While it may take some time for the drug to be fully legalized in the U.S., it is unlikely that such a burgeoning industry recognized in other developed nations will remain constrained by legalization for long. When it can be finally be legally consumed recreationally in the U.S. it will be a massive boon for an industry that is growing at a substantial rate.

Because of Canopy’s size and the maturity of its operations compared to its peers, it is well positioned to take full advantage of that development.

Growing distribution

The leading marijuana grower is working on a range of innovative initiatives aimed at increasing its distribution footprint and access to markets. This includes an alliance with Alimentation Couche-Tard to open a marijuana store in Ontario, which could lead to it being able to piggyback on Alimentation’s success in profitably operating a national chain of convenience stores.

As of April 1, 2019, appropriately licensed brick-and-mortar pot stores could open in Ontario. The number of locations was capped with only 25 licences available. This will boost its retail footprint, adding to the 28 stores already open in Saskatchewan, Manitoba, and Newfoundland.

Scaling up production

Canopy is focused on scaling up its growing activities with 4.3 million square feet of licensed capacity and the development of 1.3 million square feet underway. It also has 32 patents and 140 patent applications, which strengthen its position and will help Canopy build a wide economic moat.

The company’s leading position means it can build a formidable economic moat in an industry that will become easier to enter over time as the consumption and use of marijuana becomes more acceptable.

That enhances its long-term growth potential.

Canopy already has agreements in place to supply 70,000 kg of marijuana and that could easily double or even triple with the uptake of the drug expected to boom as it becomes more mainstream and widely accepted. A major single event, such as the U.S. removing the remaining legal barriers to the consumption of marijuana, would easily cause demand to expand exponentially.

Nonetheless, marijuana has never been commercially grown on the scale envisaged by Canopy, and that comes with risks. In such an intense growing environment, hundreds of plants can be lost through disease or poor growing conditions. There have, according to the Financial Post, been incidents where Canopy has lost large volumes of plants at its facilities.

What does it mean for investors?

Cannabis cultivation remains a high-risk industry because of a range of regulatory and legal unknowns, lack of maturity, and the social overhang associated with the negative perception associated with marijuana use. Those elements are changing, and Canopy is well positioned to capitalize on the expanding use of cannabis in our daily lives, which, with it being the leading Canadian cultivator, makes it the premier stock for investors seeking exposure to marijuana.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned. Couche-Tard is a recommendation of Stock Advisor Canada.

If You Thought Apple and Microsoft Were Big, You Need to Read This.

The steel industry produced the world's first $1 billion company in 1901, and it wasn't until 117 years later that technology giant Apple became the first-ever company to reach a $1 trillion valuation.

But what if I told you artificial intelligence (AI) is about to accelerate the pace of value creation? AI has the potential to produce several trillion-dollar companies in the future, and The Motley Fool is watching one very closely right now.

Don't fumble this potential wealth-building opportunity by navigating it alone. The Motley Fool has a proven track record of picking revolutionary growth stocks early, from Netflix to Amazon, so become a premium member today.

See the 'AI Supercycle' Stock

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »